Globela Pharma

Globela Pharma

Year of investment2021

A pharmaceutical formulations and API manufacturing company

Established in 2006, Globela is an established ISO, FDCA – India and WHO cGMP accredited formulations manufacturing company with multiple therapeutic areas including oncology, anti-infectives, gastro, CVS, etc. and sales presence across 30+ countries. It is an experienced manufacturer for high quality semi-finished, finished dosages formulation and active pharmaceutical ingredient products. It has an in-house fully equipped R&D center accredited by DSIR (Department of Scientific and Industrial Research). The company majorly caters to the needs of the Rest of the World (ROW) market, India, Africa, Asia, Latin America and Middle East and is expanding to regulated markets. The company has received UBM India Pharma Exporter of the Year Award- 2015 & 2017. The company is also a certified Star Export House by the DGFT and is classified as a preferred exporter by D&B (Dun and Bradstreet). [Other certificates: Here]

ESG & Impact

The company provides access to quality and affordable healthcare by manufacturing generic drugs. It has reach across 30+ countries many of which are developing nations including India.

The company’s R&D center focuses on developing new formulations to provide affordable medicines across various geographies across the world.

Globela is in compliance to national environmental and social rules and regulations and has developed systems and procedures to minimize overall risk and impacts due to company’s activities. Governing policies such as Quality Policy, Health & Safety Policy, Environment Policy, HR Policy etc. are listed here. It also participates in the state and central government social benefit schemes. The company is very active through its CSR initiatives like Medical van, supporting school education, skill development programs for mentally challenged, awareness programs at hospitals, etc. (Details: Here)